Ching Wan Lam

959 total citations
30 papers, 667 citations indexed

About

Ching Wan Lam is a scholar working on Infectious Diseases, Endocrinology, Diabetes and Metabolism and Neurology. According to data from OpenAlex, Ching Wan Lam has authored 30 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Neurology. Recurrent topics in Ching Wan Lam's work include COVID-19 Clinical Research Studies (9 papers), Thyroid Disorders and Treatments (6 papers) and Metabolism and Genetic Disorders (4 papers). Ching Wan Lam is often cited by papers focused on COVID-19 Clinical Research Studies (9 papers), Thyroid Disorders and Treatments (6 papers) and Metabolism and Genetic Disorders (4 papers). Ching Wan Lam collaborates with scholars based in Hong Kong, China and United States. Ching Wan Lam's co-authors include Chun Yiu Law, Wing Chow, David Tak Wai Lui, Ivan Fan‐Ngai Hung, Yu Cho Woo, Kelvin Kai‐Wang To, Anthony Raymond Tam, Kathryn Choon Beng Tan, Chi‐Ho Lee and Carol Ho Yi Fong and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and The Journal of Infectious Diseases.

In The Last Decade

Ching Wan Lam

30 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching Wan Lam Hong Kong 14 249 206 157 112 77 30 667
Valentina Citton Italy 13 92 0.4× 102 0.5× 192 1.2× 98 0.9× 143 1.9× 34 718
Şakìr Altunbaşak Türkiye 15 66 0.3× 47 0.2× 211 1.3× 71 0.6× 122 1.6× 91 809
Tatsuro Izumi Japan 16 84 0.3× 59 0.3× 71 0.5× 225 2.0× 57 0.7× 70 895
A. Rovira Spain 12 120 0.5× 99 0.5× 375 2.4× 48 0.4× 52 0.7× 28 642
Faruk İncecik Türkiye 14 66 0.3× 31 0.2× 149 0.9× 89 0.8× 69 0.9× 86 587
Pasquale F. Finelli United States 17 54 0.2× 48 0.2× 229 1.5× 98 0.9× 107 1.4× 50 677
Alison Gill United Kingdom 4 46 0.2× 142 0.7× 44 0.3× 54 0.5× 64 0.8× 6 401
Mehri Salari Iran 15 135 0.5× 29 0.1× 318 2.0× 122 1.1× 44 0.6× 92 662
Puneet Belani United States 13 193 0.8× 24 0.1× 263 1.7× 53 0.5× 61 0.8× 34 539

Countries citing papers authored by Ching Wan Lam

Since Specialization
Citations

This map shows the geographic impact of Ching Wan Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching Wan Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching Wan Lam more than expected).

Fields of papers citing papers by Ching Wan Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching Wan Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching Wan Lam. The network helps show where Ching Wan Lam may publish in the future.

Co-authorship network of co-authors of Ching Wan Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Ching Wan Lam. A scholar is included among the top collaborators of Ching Wan Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching Wan Lam. Ching Wan Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Law, Chun Yiu, David Tak Wai Lui, Eunice Y. Lau, et al.. (2024). A missense variant in SLC12A3 gene enhances aberrant splicing causing Gitelman syndrome. Clinica Chimica Acta. 564. 119924–119924. 1 indexed citations
2.
Lui, David Tak Wai, Chi‐Ho Lee, Chloe Y. Y. Cheung, et al.. (2023). A prospective follow-up on thyroid function, thyroid autoimmunity and long COVID among 250 COVID-19 survivors. Endocrine. 80(2). 380–391. 17 indexed citations
3.
Fung, Matrix Man Him, David Tak Wai Lui, K.W. Chiu, et al.. (2023). A prospective follow-up of thyroid volume and thyroiditis features on ultrasonography among survivors of predominantly mild to moderate COVID-19. PeerJ. 11. e15034–e15034. 2 indexed citations
4.
Lui, David Tak Wai, Chi‐Ho Lee, Wing Chow, et al.. (2022). The Independent Association of TSH and Free Triiodothyronine Levels With Lymphocyte Counts Among COVID-19 Patients. Frontiers in Endocrinology. 12. 774346–774346. 13 indexed citations
5.
Lui, David Tak Wai, Chi‐Ho Lee, Wing Chow, et al.. (2021). Role of non‐thyroidal illness syndrome in predicting adverse outcomes in COVID‐19 patients predominantly of mild‐to‐moderate severity. Clinical Endocrinology. 95(3). 469–477. 44 indexed citations
6.
Lui, David Tak Wai, Chi‐Ho Lee, Wing Chow, et al.. (2021). Insights from a Prospective Follow-up of Thyroid Function and Autoimmunity among COVID-19 Survivors. Endocrinology and Metabolism. 36(3). 582–589. 35 indexed citations
7.
Lui, David Tak Wai, Ivan Fan‐Ngai Hung, Chi‐Ho Lee, et al.. (2021). The Impact of Interferon Beta-1b Therapy on Thyroid Function and Autoimmunity Among COVID-19 Survivors. Frontiers in Endocrinology. 12. 746602–746602. 4 indexed citations
8.
Lui, David Tak Wai, Chi‐Ho Lee, Wing Chow, et al.. (2020). Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19. The Journal of Clinical Endocrinology & Metabolism. 106(2). e926–e935. 187 indexed citations
9.
Au, Lisa, Han‐Chih Hencher Lee, Bun Sheng, et al.. (2020). Movement disorders associated with thiamine pyrophosphokinase deficiency: Intrafamilial variability in the phenotype. Clinical Neurology and Neurosurgery. 199. 106258–106258. 5 indexed citations
10.
Cho, Sun Young, et al.. (2016). Novel large deletion in AVPR2 gene causing copy number variation in a patient with X-linked nephrogenic diabetes insipidus. Clinica Chimica Acta. 455. 84–86. 8 indexed citations
11.
Mak, Chloe Miu, et al.. (2014). Dystroglycanopathy with two novel POMT1 mutations in a Chinese boy with developmental delay and muscular dystrophy. European Journal of Paediatric Neurology. 18(4). 532–535. 5 indexed citations
12.
Poon, Wai Lun, Ho‐Ming Luk, Cheuk Wing Fung, et al.. (2012). Arginase Deficiency With New Phenotype and a Novel Mutation: Contemporary Summary. Pediatric Neurology. 47(4). 263–269. 29 indexed citations
13.
Law, Chun Yiu, et al.. (2011). Novel nonsense CDC73 mutations in Chinese patients with parathyroid tumors. Familial Cancer. 10(4). 695–699. 18 indexed citations
14.
Seto, Wai Kay, Chloe Miu Mak, David But, et al.. (2009). Mutational analysis for Wilson's disease. The Lancet. 374(9690). 662–662. 6 indexed citations
15.
Wong, Stephen Heung‐Sang, et al.. (2008). Effect of Preexercise Meals with Different Glycemic Indices and Loads on Metabolic Responses and Endurance Running. International Journal of Sport Nutrition and Exercise Metabolism. 18(3). 281–300. 26 indexed citations
16.
17.
Chen, Lei, S. Fong, Ching Wan Lam, et al.. (2007). The Familial Risk and HLA Susceptibility among Narcolepsy Patients in Hong Kong Chinese. SLEEP. 30(7). 851–858. 12 indexed citations
18.
Lam, Ching Wan, et al.. (2006). Galactorrhea—A strong clinical clue towards the diagnosis of neurotransmitter disease. Brain and Development. 28(6). 389–391. 12 indexed citations
19.
Siu, Parco M., Stephen Heung‐Sang Wong, John G. Morris, et al.. (2004). Effect of Frequency of Carbohydrate Feedings on Recovery and Subsequent Endurance Run. Medicine & Science in Sports & Exercise. 36(2). 315–323. 15 indexed citations
20.
Chan, Paul K.S., Ching Wan Lam, Tak Hong Cheung, et al.. (2002). Human Papillomavirus Type 16 Intratypic Variant Infection and Risk for Cervical Neoplasia in Southern China. The Journal of Infectious Diseases. 186(5). 696–700. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valentina Citton Breakdown of academic impact, for papers by Şakìr Altunbaşak Breakdown of academic impact, for papers by Tatsuro Izumi Breakdown of academic impact, for papers by A. Rovira Breakdown of academic impact, for papers by Faruk İncecik Breakdown of academic impact, for papers by Pasquale F. Finelli Breakdown of academic impact, for papers by Alison Gill Breakdown of academic impact, for papers by Mehri Salari Breakdown of academic impact, for papers by Puneet Belani
Rankless by CCL
2026